Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Determination of genetic predisposition to patent ductus arteriosus in preterm infants.

Pediatrics - 1 Apr 2009

Dagle John M, Lepp Nathan T, Cooper Margaret E, Schaa Kendra L, Kelsey Keegan J P, Orr Kristin L, Caprau Diana, Zimmerman Cara R, Steffen Katherine M, Johnson Karen J, Marazita Mary L, Murray Jeffrey C

Abstract excerpt

OBJECTIVE: Patent ductus arteriosus is a common morbidity associated with preterm birth. The incidence of patent ductus arteriosus increases with decreasing gestational age to approximately 70% in infants born at 25 weeks' gestation. Our major goal was to determine if genetic risk factors play a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CRF Receptor, Type 1
Share to Ductus Arteriosus, Patent

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Infant, Premature

Share to Infant, Premature, Diseases

Share to Intramolecular Oxidoreductases

Share to Receptors, Corticotropin-Releasing Hormone

Share to TNF Receptor-Associated Factor 1

Share to Transcription Factor AP-2

Source

Open in PubMed Open full text

Identifiers

PMID: 19336370
DOI: 10.1542/peds.2008-0313
PMCID: PMC2734952

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-19336370-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Determination of genetic predisposition to patent ductus arteriosus in preterm infants.PMID 19336370Read ↗

Association Between Genetic Polymorphisms in the Prostaglandin Pathway and the Development of Patent Ductus Arteriosus in Preterm InfantsSemantic proximity Read ↗

Genetics of patent ductus arteriosus susceptibility and treatment.Semantic proximity Read ↗

Genetics of the patent ductus arteriosus (PDA) and pharmacogenetics of PDA treatment.Semantic proximity Read ↗

Genetic Modifiers of Patent Ductus Arteriosus in Term Infants.Semantic proximity Read ↗

Patterns of gene expression in the ductus arteriosus are related to environmental and genetic risk factors for persistent ductus patency.Semantic proximity Read ↗

Genetic basis of preterm birth.Semantic proximity Read ↗

Genetic polymorphisms and spontaneous preterm birth.Semantic proximity Read ↗

Single nucleotide polymorphisms in AGTR1, TFAP2B, and TRAF1 are not associated with the incidence of patent ductus arteriosus in Japanese preterm infants.Semantic proximity Read ↗

Polymorphisms in CYP2C9 are associated with response to indomethacin among neonates with patent ductus arteriosus.Semantic proximity Read ↗

Effects of Advancing Gestation and Non-Caucasian Race on Ductus Arteriosus Gene Expression.Semantic proximity Read ↗

Progesterone receptor genotype, family history, and spontaneous preterm birth.Semantic proximity Read ↗

Comparative Analysis of Machine Learning Algorithms Evaluating the Single Nucleotide Polymorphisms of Metabolizing Enzymes with Clinical Outcomes Following Intravenous Paracetamol in Preterm Neonates with Patent Ductus Arteriosus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.